European & Developing Countries Clinical Trials Partnership (EDCTP)

Slides:

Advertisements

Similar presentations

EuroPa - Establishment of an European Network of Excellence Müller, M.(1), Neumann, H.(2), Jungraithmeier, T., Almann, F. J., Wagner, M., Smith, S. (1)

Advertisements

Research Leaders: Meeting the challenge Mark Walport 19 November 2008.

A Network for the Coordination and Advancement of Sub-Saharan Africa-EU Science and Technology Cooperation CAAST-Net is supported under.

African Capacity Development needs Alioune DIEYE, EDCTP-DCCC Chair Consensus meeting of the EDCTP-II Brussels, September 2010.

Ensuring Access to Data and Information - Capacity Building for Tropical Diseases Lester Chitsulo Special Programme for Research and Training in Tropical.

SAVING LIVES AND CREATING IMPACT EU investment in poverty-related neglected diseases.

Pharmaceuticals and Global Health Inequalities and Innovation in the 21 st Century.

PPPs and innovation Opportunities and challenges within a European public-public partnership.

"3 by 5" progress December 2005 Progress on global access to HIV antiretroviral therapy | 12 April |2 | Antiretroviral therapy coverage in low-

1 EDCTP EUROPEAN AND DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP _____________________________________ Member States Workshop, 27 th -28 th September,

EDCTP as a model for Europe-Africa partnership on HIV/AIDS research – Achievements & Future Directions Dr Gabrielle Breugelmans North-North Networking.

European & Developing Countries Clinical Trials Partnership (EDCTP) Towards EDCTP2 22 July 2014 Melbourne, Australia Ole F. Olesen, Ph.D., HD Director.

Implementation of health research funding under H2020 SC 1- “Health, demographic change and wellbeing “ Elmar Nimmesgern PhD DG Research and Innovation.

TUBERCOLOSIS Agis Terzidis, Paediatrician Spyridon Gialamas, Medical Doctor SEMINAR ON TROPICAL AND TRAVEL MEDICINE AT TTCIH IFAKARA 25 JUNE 2009.

Report from the Africa Summit (GRC Regional Consultation) Dr Eino Mvula CEO: NCRST 27 May 2015.

EoI assesment and presentation NCP 24 October 2002 Confronting the major communicable diseases linked to poverty Health Directorate F3 unit: Poverty related.

KNCV Tuberculosis Foundation’s support to The National Tuberculosis Control Program By Verena Mauch, Sr TB Consultant.

1 EDCTP THE NEXT DECADE: Towards a Collaborative ERA fighting AIDS, malaria, tuberculosis & tropical diseases Proposal for EDCTP-II to the European Council.

Consensus meeting on a proposal for a second phase of EDCTP A welcome note Patrice Debre – Vice Chair (on behalf of Hannah Akuffo Chairperson) EDCTP.

EMERGING AND RE-EMERGING INFECTIOUS DISEASES: A CONTINUOUS CHALLENGE FOR EUROPE STOA - AVIESAN Workshop June 19th 2012, European Parliament, Bruxelles.

EQUI - TB Knowledge Programme Quality Assured TB Care for Poor People in Resource Constrained settings 2001 – 2006 Purpose: To promote implementation of.

22 March 2012 Europe and ACP together against tuberculosis European Parliament, Rue Wiertz 60 BRUSSELS Charles S Mgone EDCTP Executive Director.

The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.

Global Health Research – Priority Areas and The Role of Norwegian Institutions State Secretary Ms Elisabeth Aspaker.

The Global Health Clinical Trials Programme The goal of the Global Health Clinical Trials Programme is to promote and make easier the conduct of non-commercial.

T reatment A ction G roup Update on Global TB Research By Claire Wingfield Treatment Action Group Advisory Council for the Elimination of Tuberculosis.

European and Developing Countries Clinical Trials Partnership AEMI Seminar Dec 2010 Dr Thomas Nyirenda South-South Networking and Capacity Development.

Operational Research in the 21 st Century. International Union Against Tuberculosis and Lung Disease (The Union) World’s oldest humanitarian organization.

DOTS Expansion Working Group Meeting Engaging Professional Associations in TB Control Paris, 15 October 2008 Dr J.M. Chakaya Chair, DEWG.

Innovation Pathway AHSN Stakeholder Event Russ Watkins Assistant Director – Business Innovation & Improvement Newcastle Hospitals.

INTEGRATED PROJECT MUCOSAL VACCINES FOR POVERTY-RELATED DISEASES MUVAPRED MUVAPRED Project Summary Human Immunodeficiency Virus and Mycobacterium tuberculosis.

Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,

Registering and analyzing malaria clinical trials in Africa: the PACT registry initiative Vittoria Lutje*^, Annette Gerritsen**, Nandi Siegfried***. Paul.

1 EU-funded health research activities against TB: FP6 actions and perspectives toward FP7 DG Research - European Commission 22 MARCH 2007.

IRSS – Centre Muraz : A collaborative research initiative for the promotion of Health in Africa Maxime Koiné DRABO MD, MPH, PhD.

OCTOBER 2014 TREATMENT ACTION GROUP MIKE FRICK. Annual Global Plan Research Funding Targets versus 2013 Funding $600,000,000 $800,000,000 $400,000,000.

A An Eastern Partnership Conference An Eastern Partnership Conference 5-6 th December 2011, Kiev 5-6 th December 2011, Kiev.

Clinical trials in Framework programme 7 (FP7) EU Judita Kinkorová 2. Národní konference o doporučených postupech, Olomouc 13. listopadu 2010.

European HIV/AIDS programmes: EDCTP as a model of Europe-Africa partnership 19 July 2011 IAS 2011 Rome, Italy Charles S Mgone EDCTP Executive Director.

Development, utilisation and retention of capacity for clinical research in sub-Saharan Africa 19 July 2011 IAS 2011 Rome, Italy Charles S Mgone EDCTP.

Building partnerships The Velma E. Schmidt Critical Childhood Public Policy Research Initiative and other international collaborations in early childhood.

Tuberculosis is a global public health issue. The Role of the International Agencies Introduction TB which stands for Tuberculosis is a rather infectious.

Dr. Manuel ROMARÍS Poverty-related Diseases European Commission Research DG Microbicides BXL, 07 October 2005 HIV/AIDS Research in the Sixth Framework.

The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.

International perspectives on human gene editing: South Africa KEYMANTHRI MOODLEY DIRECTOR & PROFESSOR CENTRE FOR MEDICAL ETHICS & LAW DEPARTMENT OF MEDICINE.

HORIZON 2020 SC1-Health, demographic change and wellbeing challenge Марина Николовска Министерство за образование и наука

WG report backs: New TB Vaccines & TB/HIV INAT Meeting November 12, 2010 Berlin.

Tuberculosis in the EU: An ECDC perspective World TB day European Parliament 22 March 2007 Zsuzsanna Jakab ECDC Director.

Multi-disciplinary University Traditional Health Initiative (MUTHI): Building Sustainable Research Capacity on Plants for Better Public Health in Africa.

International Partnership for Microbicides Approach to HIV Treatment and Care in Future IPM Microbicide Trials Pam Norick, Chief of External Relations.

Research and Innovation for Maternal and Newborn Health, Brussels – Square Meeting Centre, 8 th Dec 2015 Beyond Ethics in Outbreak Research NAS, Clinical.

Policy Research and Innovation Research and Innovation ESOF Copenhagen, Wednesday June 25, 2014 Building Global Partnerships: Sharing Discovery & Innovation;

WHO’s policy priorities and projects

European-Comparative Effectiveness Research on online Depression Treatment E-COMPARED is funded by the European Community’s Seventh Framework.

State of the TB Alliance

Dr Ousmane Sarr WANETAM

Expanding ARV treatment in developing countries: Issues and Prospects

International cooperation in Health

Work Programme The social challenge “Health, Demographic Change and Wellbeing” Maia Okujava NCP for Health, Demographic Change and weii-being,

HIV/AIDS epidemics around the Baltic sea and public health implication

Accessing Medicines in Africa Prospects and challenges

The Commission Strategy on TB vaccine research

"3 by 5" progress December 2005.

Antiretroviral therapy coverage in sub-Saharan Africa,

Conflicting of interest disclosure: None

Every Mother, Every Child: Closing the Gaps in HIV Management

Name: Olalekan A. Uthman, MBBS MPH PhD

Title Southampton Clinical Research Facility Southampton Biomedical Research Centre Clinical research in Southampton is a partnership between University.

Clinical research in Southampton is a partnership between University Hospital Southampton NHS Foundation Trust and the University of Southampton, combining.

Presentation transcript:

European & Developing Countries Clinical Trials Partnership (EDCTP) Dr Ole Olesen | Director of North-North Cooperation

EDCTP funding streams (simplified) Open calls-for-proposals (around a dedicated topic) Clinical Trials in sub-Saharan Africa (85%) Collaborations between research teams in Europe and Africa (and elsewhere) Capacity building activities (15%) Fellowships, networking, regulatory, ethics

EDCTP2 project portfolio by intervention €4.1 M 14 grants (2014-2017) €24.4 M 18 grants Fellowships €12.2 M 47 grants €217.8 M 34 grants €258.5 M 113 grants Vaccines €82.7 M 9 grants Diagnostics €30.9 M 10 grants Clinical Management €36.3 M 4 grants Drugs €67.9 M 11 grants *including treatment and prevention. ***cross-cutting activities including regional networks of excellence

Clinical trials by disease Intervention type by disease for clinical trials projects 66 M 34.4 M

THANK YOU WWW.EDCTP.ORG

TB projects in EDCTP2: first 3 years Acronym Study topic Coordinator Country No. participants EDCTP grant StopTB/HIV at one Diagnostics Liverpool School of Tropical Medicine (LSTM) United Kingdom 5 €1,413,749 Screen TB Stellenbosch University South Africa 9 €2,995,574 DIAMA* Centre National Hospitalier de Pneumo-Phtisiologie Benin 13 €2,967,203 Predict TB €7,722,491 RaPaed TB Ludwig-Maximilians-Universitaet Muenchen (LMU) Germany 10 €2,999,644 PanACEA Drugs Stichting Katholieke Universiteit- Radboudumc (RUMC) Netherlands 16 €11,394,775 VirTUAL University of Liverpool 6 €2,058,003 POR TB consortium Vaccines Statens Serum Institut (SSI) Denmark 7 €13,788,161 MTBVAC - Newborns Biofabri S.L. Spain €5,537,093 priMe Vakzine Projekt Management GmbH 14 €12,493,179 POI-TB Aeras Global Tuberculosis Foundation NPC €2,575,019 €65,944,891